FI57399B - FREEZING FOR ANTIBACTERIAL VERIFICATION OF IMMEDIATE FACTORS - Google Patents
FREEZING FOR ANTIBACTERIAL VERIFICATION OF IMMEDIATE FACTORS Download PDFInfo
- Publication number
- FI57399B FI57399B FI105473A FI105473A FI57399B FI 57399 B FI57399 B FI 57399B FI 105473 A FI105473 A FI 105473A FI 105473 A FI105473 A FI 105473A FI 57399 B FI57399 B FI 57399B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- chloride
- carbon atoms
- alkyl group
- hydrogen
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title description 5
- 230000008014 freezing Effects 0.000 title 1
- 238000007710 freezing Methods 0.000 title 1
- 238000012795 verification Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 150000002460 imidazoles Chemical class 0.000 claims description 4
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 150000004985 diamines Chemical class 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 14
- -1 n-octyl Chemical group 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- HQVSLRILSKVFKE-UHFFFAOYSA-N 2-(3-octylimidazol-1-ium-1-yl)acetic acid chloride Chemical compound [Cl-].C(CCCCCCC)[N+]1=CN(C=C1)CC(=O)O HQVSLRILSKVFKE-UHFFFAOYSA-N 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- KLMZKZJCMDOKFE-UHFFFAOYSA-N 1-octylimidazole Chemical compound CCCCCCCCN1C=CN=C1 KLMZKZJCMDOKFE-UHFFFAOYSA-N 0.000 description 3
- IATNTPRVOWFGAL-UHFFFAOYSA-N 3-octyl-1h-imidazol-3-ium;chloride Chemical compound [Cl-].CCCCCCCC[NH+]1C=CN=C1 IATNTPRVOWFGAL-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- IJSBSKMMAFTHKT-UHFFFAOYSA-M ethyl 2-(3-octylimidazol-1-ium-1-yl)acetate chloride Chemical compound [Cl-].C(CCCCCCC)[N+]1=CN(C=C1)CC(=O)OCC IJSBSKMMAFTHKT-UHFFFAOYSA-M 0.000 description 3
- PDWGEBYZOGWPHG-UHFFFAOYSA-M methyl 2-(3-octylimidazol-1-ium-1-yl)acetate chloride Chemical compound [Cl-].C(CCCCCCC)[N+]1=CN(C=C1)CC(=O)OC PDWGEBYZOGWPHG-UHFFFAOYSA-M 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 125000006286 dichlorobenzyl group Chemical group 0.000 description 2
- QFTYSVGGYOXFRQ-UHFFFAOYSA-N dodecane-1,12-diamine Chemical compound NCCCCCCCCCCCCN QFTYSVGGYOXFRQ-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- CKIOGGCNLLYYBT-UHFFFAOYSA-N CCCCCCCC[N+](C=C1)=CN1C(CC(O)=O)=O.[Cl-] Chemical compound CCCCCCCC[N+](C=C1)=CN1C(CC(O)=O)=O.[Cl-] CKIOGGCNLLYYBT-UHFFFAOYSA-N 0.000 description 1
- AXQBCBHQTBUKBL-UHFFFAOYSA-M CCCCCCCC[N+](C=C1)=CN1C(OC)=O.[Cl-] Chemical compound CCCCCCCC[N+](C=C1)=CN1C(OC)=O.[Cl-] AXQBCBHQTBUKBL-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical group [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940006460 bromide ion Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940089960 chloroacetate Drugs 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-M chloroacetate Chemical compound [O-]C(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-M 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 229940106681 chloroacetic acid Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- QABLOFMHHSOFRJ-UHFFFAOYSA-N methyl 2-chloroacetate Chemical compound COC(=O)CCl QABLOFMHHSOFRJ-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000563 toxic property Toxicity 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
ΓβΙ f11.KUULUTUSJULKAISU C 7 7 Q Q jgTj LBJ V1') UTLÄGG N I NGSSKRI FT ^ ’07? ^ latent n.oddelnt ^ ^ (51) Kv.ik?/intci.3 c 07 D 233/5^, 235/06 SUOM I—FI N LAN D (21) ρ·μ*ι«ι^·ιμ«*—p*t«ot»i»eiu»ini 105U/73 (22) HaktmiipUvl—Ameknlngadtg 05.0U.T3 (23) Alkupihrt—GHtl|h«t*d«f 05.0U.73ΓβΙ f11.ANVERTISEMENT PUBLICATION C 7 7 Q Q jgTj LBJ V1 ') UTLÄGG N I NGSSKRI FT ^ '07? ^ latent n.oddelnt ^ ^ (51) Kv.ik? /intci.3 c 07 D 233/5 ^, 235/06 SUOM I — FI N LAN D (21) ρ · μ * ι «ι ^ · ιμ« * —P * t «ot» i »eiu» ini 105U / 73 (22) HaktmiipUvl — Ameknlngadtg 05.0U.T3 (23) Alkupihrt — GHtl | h «t * d« f 05.0U.73
(41) Tullut lultriMkal — BIMt offwitll| 06.10.7U(41) Tullut lultriMkal - BIMt offwitll 06.10.7U
Patentti· Ja rekisterihallitus (44) NlhttviUp^on J. kuuluuhun pvm·- on A, flnPatent · And the National Board of Registration (44) NlhttviUp ^ is J. belongs to date · - is A, fln
Patent- och registeretyreleen Amekm utiajd och utUkriftan pubiicund 30.04.00 (32)(33)(31) Pyydetty «tuolkMt —B*ftrd priorittt (71) Imperial Chemical Industries Limited, Imperial Chemical House, Millbank, London S.W.l, Englanti-England(GB) ' (72) Philip Neil Edwards, Macclesfield, Cheshire, Englanti-England(GB) (7U) Oy Kolster Ab (5U) Menetelmä antibakteerisesti vaikuttavien imidatsolijohdannaisten valmistamiseksi - Förfarande för framställning av antibakteriellt verkande imidazolderivat (6l) Lisäys patenttiin 55 831 - Tillägg till patent 55 831 Tämä keksintö kohdistuu menetelmään niiden patentissa 55 831 olevien antibakteerisesti vaikuttavien imidatsolijohdannaisten valmistamiseksi, joilla on kaava: R2 r1 r2 R1 v—r y-f -- A -.(X)f> 1Patent and registration duty Amekm utiajd och utUkriftan pubiicund 30.04.00 (32) (33) (31) Requested «tuolkMt —B * ftrd priorittt (71) Imperial Chemical Industries Limited, Imperial Chemical House, Millbank, London SW1, England-England ( GB) '(72) Philip Neil Edwards, Macclesfield, Cheshire, England-England (GB) (7U) Oy Kolster Ab (5U) Process for the preparation of antibacterial imidazole derivatives - Preparation of antibacterial active imidazole derivatives (6l) This invention relates to a process for the preparation of antibacterial imidazole derivatives according to patent 55 831 having the formula: R2 (r) r1 R1 v-r yf - A -. (X) f> 1
'u U'u U
R RR R
1.2 ..1.2 jossa R ja R ovat vetyatomeja, tai R ja R yhdessä muodostavat kondensoituneen bentseenirenkaan; R on 6-1U hiiliatomia sisältävä alkyyliryhmä, bentsyyliryhmä, jonka bentseenirenkaassa on 0-5 kloorisubstituenttia, tai 3-alkoksi-2-hydroksipro-1.2 ..1.2 wherein R and R are hydrogen atoms, or R and R together form a fused benzene ring; R is an alkyl group having 6 to 1 carbon atoms, a benzyl group having 0 to 5 chlorine substituents on the benzene ring, or 3-alkoxy-2-hydroxypropyl.
UU
pyyliryhmä, jonka alkoksiosassa on U-8 hiiliatomia; R on vetyatomi tai 1-3 hiili-a pyyl group having U-8 carbon atoms in the alkoxy moiety; R is a hydrogen atom or 1-3 carbon
2Q2Q
atomia sisältävä alkyyliryhmä; (x)2 esittää kahta monoanionia ja A on siltaketju, 2 57399 jolla on kaava -(CHj — CONH.(CH ) —NH-CO(CHj -2 m 2 n 2 m jossa n on 2-12 ja m on 1 tai 2.an atom-containing alkyl group; (x) 2 represents two monoanions and A is a bridging chain, 2 57399 of the formula - (CH 2 - CONH. (CH) -NH-CO (CH 2 -2 m 2 n 2 m where n is 2-12 and m is 1 or 2.
Keksinnön mukaiselle menetelmälle on tunnusomaista, että imidatsolyyli-alkaanihappojohdannainen, jolla on kaava S—^The process according to the invention is characterized in that the imidazolylalkanoic acid derivative of the formula S-
O I I 5 0 IIO I I 5 0 II
R -N 'M N-(CHj- COOR? -YT Vx"· 2 m l· 1 2 3 1+ . 5 jossa R , R , R , R jam merkitsevät samaa kuin edellä, R on vety tai 1-1+ hiiliatomia sisältävä alkyyliryhmä, ja ^ on monoanioni, saatetaan reagoimaan diamii-nin kanssa, jolla on kaava NH (CH ) HH„, jossa n merkitsee samaa kuin edellä.R -N'M N- (CH 2 -COOR? -YT Vx "· 2 ml · 1 2 3 1+. 5 where R, R, R, R and have the same meaning as above, R is hydrogen or 1-1 + carbon atoms an alkyl group, and ^ is a monoanion, is reacted with a diamine of the formula NH (CH) HH n, where n is as defined above.
Reaktio voidaan suorittaa ilman laimenninta tai liuotinta, tai edullisimmin laimentimessa tai liuottimessa, esim. tolueenissa, etanolissa tai metanolis-sa tai niiden seoksessa. Reaktiota voidaan kiihdyttää tai täydentää kuumentamalla, esim. suorittamalla se laimentimen tai liuottimen kiehumapisteessä. Kun R^ on vety, suoritetaan reaktio mieluimmin aineen, kuten disykloheksyylikarbodi-imidin läsnäollessa, joka aikaansaa peptidisidoksen, laimentimessa tai liuottimessa, esim.The reaction may be carried out without a diluent or solvent, or most preferably in a diluent or solvent, e.g. toluene, ethanol or methanol or a mixture thereof. The reaction may be accelerated or supplemented by heating, e.g., at the boiling point of the diluent or solvent. When R 1 is hydrogen, the reaction is preferably carried out in the presence of an agent such as dicyclohexylcarbodiimide which provides a peptide bond in a diluent or solvent, e.g.
etyyliasetaatissa tai dimetyyliformamidissa.in ethyl acetate or dimethylformamide.
3 . .3. .
Kun R on alkyyliryhma, on se mieluiten suoraketjumen alkyyliryhma, esim.When R is an alkyl group, it is preferably a straight chain alkyl group, e.g.
n-oktyyli-, n-dekyyli- tai n- dodekyyliryhmä.an n-octyl, n-decyl or n-dodecyl group.
Kun R on valinnaisesti substituoitu bentsyyliryhmä, on se mieluiten 1+- kloori- tai 2,l+-diklooribentsyyliryhmä.When R is an optionally substituted benzyl group, it is preferably a 1 + chloro or a 2,1 + dichlorobenzyl group.
3 ...3 ...
Kun R on 3-alkoksi-2-hydroksipropyyliryhma, on se mieluiten suoraketjumen 1+-8 hiiliatomia sisältävä alkoksiryhmä, esim. n-heptyylioksiryhmä.When R is a 3-alkoxy-2-hydroxypropyl group, it is preferably an alkoxy group having 1 + -8 carbon atoms in the straight chain, e.g. an n-heptyloxy group.
1* .1 *.
Kun R on alkyyliryhma, on se mieluiten metyyliryhma.When R is an alkyl group, it is preferably a methyl group.
on sopivasti halogenidi-ioni, esim. kloridi-ioni tai bromidi-ioni, tai sulfonihaposta johdettu anioni, esim. metaanisulfonaatti- tai tolueeni-p-sulfonaat- tianioni.is suitably a halide ion, e.g. a chloride ion or a bromide ion, or an anion derived from a sulphonic acid, e.g. a methanesulphonate or toluene p-sulphonate anion.
Edullisesti m on 1 ja n on 1+,6,8,10 tai 12.Preferably m is 1 and n is 1 +, 6,8,10 or 12.
Erityisen edullisesti keksinnön mukaisella menetelmällä voidaan valmistaa 1.2 1 .Particularly preferably, 1.2 1 can be prepared by the method according to the invention.
sellaisia kaavan I mukaisia yhdisteitä, joissa R ja R ovat vetyatomeja tai R ja 2 3 R yhdessä muodostavat kondensoituneen bentseenirenkaan; F on 8-10 hiiliatominen cuoraketjuinen alkyyliryhmä, U-klooribentsyyliryhmä tai 2,l+-diklooribentsyyliryhmä; k 20 R on vety tai metyyliryhma; (X)^ esittää kahta kloridi-, bromidi- tai metaanisul-fonaattianionia; ja ketjussa A m on 1 ja n on 1+,6,8,10 tai 12.compounds of formula I in which R and R are hydrogen atoms or R and 23 R together form a fused benzene ring; F is a chloro-chain alkyl group having 8 to 10 carbon atoms, a U-chlorobenzyl group or a 2,1 + dichlorobenzyl group; k 20 R is hydrogen or methyl; (X) ^ represents two chloride, bromide or methanesulfonate anions; and in the chain A m is 1 and n is 1 +, 6,8,10 or 12.
3 573993,57399
Erityisen edullisia yhdisteitä, joita keksinnön mukaisella menetelmällä voidaan valmistaa, ovat 1,1'-dekametyleeni bis(karbamoyylimetyyli)-di-(3-n-oktyyli-imidatsoliumkloridi) ja 1,1'-dodekametyleenibis(karbamoyylimetyyli)-di-(3-n-oktyyli-imidat soiiumkloridi).Particularly preferred compounds which can be prepared by the process of the invention are 1,1'-decamethylene bis (carbamoylmethyl) -di- (3-n-octylimidazolium chloride) and 1,1'-dodecamethylene bis (carbamoylmethyl) -di- (3- n-octyl imidates (sodium chloride).
Lähtöaineena käytetty kaavan II mukainen imidatsolyylialkaani-happojohdannainen valmistetaan saattamalla kaavan R2 R1 \_/The imidazolylalkanoic acid derivative of formula II used as a starting material is prepared by reacting R 2 of formula R2
- III- III
r3-n n y mukainen yhdiste reagoimaan yhdisteen kanssa, jolla on kaava X-(CH^) -COOR^ 2 m „ sekä, mikäli on vety ja halutaan käyttää sellaista kaavan II mukaista yhdis tettä, jossa on alkyyliryhmä, esteröimällä alkoholin kanssa, jolla on kaava R^OH, esimerkiksi tionyylikloridin tai happamen ioninvaihtohartsin läsnäollessa.reacting a compound of formula R3-n ny with a compound of formula X- (CH2) -COOR ^ 2 m „and, if hydrogen and it is desired to use a compound of formula II having an alkyl group, by esterification with an alcohol of formula formula R 1 OH, for example in the presence of thionyl chloride or an acidic ion exchange resin.
Keksinnön mukaisella menetelmällä valmistetuilla tuotteilla on arvokkaita antibakteerisia ominaisuuksia,', ne tappavat monenlaisia, sekä gram-positiivisia että gram-negatiivisia bakteereita, kuten käy ilmi sarjalaimennuskokeista. Ne ovat siksi hyödyllisiä sekä ympäristön antiseptisinä ja tulehduksia torjuvina aineina, että pre-operatiivisina ihonpuhdistajina, ne ovat myös hyödyllisiä suun hygieniassa, esimerkiksi vastustaen hammaskiven muodostumista tai estäen ientulehduksia. Keksinnön mukaisella menetelmällä valmistetuilla yhdisteillä ei ole havaittavia myrkyllisiä ominaisuuksia annettuna suun kautta hiirille aina 250 mg/kg saakka.The products prepared by the method of the invention have valuable antibacterial properties, killing a wide variety of bacteria, both gram-positive and gram-negative, as shown by serial dilution experiments. They are therefore useful both as environmental antiseptics and anti-inflammatory agents and as pre-operative skin cleansers, they are also useful in oral hygiene, for example in resisting tartar formation or preventing gingivitis. The compounds of the invention do not have detectable toxic properties when administered orally to mice up to 250 mg / kg.
Keksintöä kuvataan seuraavilla esimerkeillä.The invention is illustrated by the following examples.
Esimerkki 1 1-n-oktyyli-3-metoksikarbonyylimetyyli-imidatsoliumkloridia (1,0 g) dodeka-metyleenidiamiinia (0,3^ g) sekoitetaan keskenään metanolissa (3,0 ml) kahden tunnin ajan, ja metanoli poistetaan keittämällä normaalipaineessa. Jäännös liuotetaan veteen (5,0 ml), pH säädetään 12:ksi, ja uutetaan kloroformilla (5x5 ml). Yhdistetyt uutteet haihdutetaan kuiviin ja jäännös hierretään asetonilla, jolloin saatu valkoinen sakka suodatetaan, pestään asetonilla ja kuivataan. Täten saadaan 1,1'-dodekametyleenibis(karbamoyylimetyyli)di(3-n-oktyyli-imidatsoliumkloridi), sulamispiste 11*6-11*8°C.Example 1 1-n-Octyl-3-methoxycarbonylmethylimidazolium chloride (1.0 g) dodecamethylenediamine (0.3 g) is stirred together in methanol (3.0 ml) for two hours and the methanol is removed by boiling under normal pressure. The residue is dissolved in water (5.0 ml), the pH is adjusted to 12, and extracted with chloroform (5 x 5 ml). The combined extracts are evaporated to dryness and the residue is triturated with acetone, whereupon the resulting white precipitate is filtered off, washed with acetone and dried. There is thus obtained 1,1'-dodecamethylene bis (carbamoylmethyl) di (3-n-octylimidazolium chloride), melting point 11 * 6-11 * 8 ° C.
Lähtöaineena käytetty 1-n-oktyyli-3_metoksikarbonyylimetyyli-imidatsolium-kloridi voidaan valmistaa seuraavasti:The starting 1-n-octyl-3-methoxycarbonylmethylimidazolium chloride can be prepared as follows:
Kloorietikkahappoa (112 g) ja 1-n-oktyyli-imidatsolia (11+5 g) kuumennetaan ja sekoitetaan typpiatomosfäärissä 1*5 min ajan, sitten annetaan jäähtyä. Kun seosChloroacetic acid (112 g) and 1-n-octylimidazole (11 + 5 g) are heated and stirred under a nitrogen atmosphere for 1 * 5 min, then allowed to cool. When the mixture
It 57399 on jäähtynyt 150°C:en, lisätään asetonitriiliä (1+00 ml) (aluksi hyvin hitaasti), sitten lisätään asetonia (500 ml). Seoksen jäähtyessä edelleen, kiteytyy sakka, joka suodatetaan, pestään asetonilla ja kuivataan, tä31öin saadaan 1-n-oktyyli- 3-hydroksikarbonyylimetyyli-imidatsoliumkloridi, sulamispiste 120-122°C.It 57399 has cooled to 150 ° C, acetonitrile (1 + 00 ml) is added (initially very slowly), then acetone (500 ml) is added. On further cooling, the precipitate crystallizes, which is filtered, washed with acetone and dried to give 1-n-octyl-3-hydroxycarbonylmethylimidazolium chloride, m.p. 120-122 ° C.
1-n-oktyyli-3_hydroksikarbonyyliraetyyli-imidatsoliumkloridia (1,0 g) lisätään metanolin (1,5 ml) ja tionyylikloridin (0,1+35 g) seokseen, ja näin saatua seosta sekoitetaan 3 tunnin ajan. Kaikki haihtuva materiaali haihdutetaan vakuumissa ja saadaan kumimaista 1-n-oktyyli-3-metoksi-karbonyylimetyyli-imidat-soliumkloridia. Toisaalta voidaan lähtöaineen käytetty 1-n-oktyyli-3-metoksi-karbonyyli-imidatsoliumkloridi valmistaa seuraavasti: 1-n-oktyyli-imidatsolia (10,0 g), metyyliklooriasetaattia (10 ml) ja metanolia (50 ml) refluksoidaan typpiatomosfäärissä 18 tunnin ajan. Haihdutettaessa metanoli ja ylijäämä klooriasetaattia vakuumissa, saadaan paksu öljymäinen 1-n-oktyyli-3-metoksikarbonyylimetyyli-imidatsoliumkloridi, jota ei voida kiteyttää. Ohutkerroskromatografinen analyysi (silikageeli; eluenttina isopropanoli/ vesi/etikkahappo (3:1:1))» osoittaa pääasiassa yhden läikän, jossa on jälkiä lähtöaineesta.1-n-Octyl-3-hydroxycarbonylacetylimidazolium chloride (1.0 g) is added to a mixture of methanol (1.5 ml) and thionyl chloride (0.1 + 35 g), and the mixture thus obtained is stirred for 3 hours. All volatiles are evaporated in vacuo to give gummy 1-n-octyl-3-methoxycarbonylmethylimidazole chloride. On the other hand, the 1-n-octyl-3-methoxycarbonylimidazolium chloride used as a starting material can be prepared as follows: 1-n-octylimidazole (10.0 g), methyl chloroacetate (10 ml) and methanol (50 ml) are refluxed under a nitrogen atom for 18 hours. . Evaporation of methanol and excess chloroacetate in vacuo gives a thick oily 1-n-octyl-3-methoxycarbonylmethylimidazolium chloride which cannot be crystallized. Thin layer chromatographic analysis (silica gel; eluent isopropanol / water / acetic acid (3: 1: 1)) »shows mainly one spot with traces of starting material.
Toisaalta voidaan välituotteena käytetty 1-n-oktyyli-3~hydroksikarbonyyli-metyyli-imidatsoliumkloridi valmistaa seuraavasti: 1-n-oktyyli-imidatsolin (18,0 g), natriumklooriasetaatin (1U,5 g)-metanolin (1+0 ml) ja riittävän määrän vettä liuottamaan natriumsuolan seosta, kuumennetaan refluksoiden 20 tunnin ajan, pitäen pH 7:nä lisäämällä natriumkarbonaattia. Jäähdytetty seos haihdutetaan, liuotetaan veteen (150 ml) ja pestään tolueenilla. Vesifaasi haihdutetaan ja jäännös hierretään asetonilla. Saatu sakka suodatetaan öljyn ja veden seoksesta ja kaikki öljy poistetaan huolellisesti. Öljy erotetaan, trituroidaan kloorivedyn eetteriliuoksella ja saatu sakka suodatetaan ja kuivataan eksikaattorissa. Kuivaa sakkaa liuotetaan mahdollisimman pieneen tilavuuteen kloroformia, jäännössakka erotetaan suodattamalla, kloroformiliuos haihdutetaan ja jäännös trituroidaan asetonilla. Kiinteä aine suodatetaan, kuivataan ja uudel-leenkiteytetään asetonitriilistä, jolloin saadaan 1-n-oktyyli-3-hydroksikarbonyy-limetyyli-imidatsoliumkloridi, sulamispiste 120,5_121,5°C.On the other hand, the intermediate 1-n-octyl-3-hydroxycarbonylmethylimidazolium chloride can be prepared as follows: 1-n-octylimidazole (18.0 g), sodium chloroacetate (1U, 5 g) -methanol (1 + 0 ml) and sufficient water to dissolve the sodium salt mixture is heated at reflux for 20 hours, maintaining the pH at 7 by the addition of sodium carbonate. The cooled mixture is evaporated, dissolved in water (150 ml) and washed with toluene. The aqueous phase is evaporated and the residue is triturated with acetone. The resulting precipitate is filtered from a mixture of oil and water and all oil is carefully removed. The oil is separated, triturated with ethereal hydrogen chloride and the precipitate obtained is filtered off and dried in a desiccator. The dry precipitate is dissolved in as little chloroform as possible, the residual precipitate is filtered off, the chloroform solution is evaporated and the residue is triturated with acetone. The solid is filtered, dried and recrystallized from acetonitrile to give 1-n-octyl-3-hydroxycarbonylmethylimidazolium chloride, mp 120.5-121.5 ° C.
Esimerkki 2 1-n-oktyyli-3-etoksikarbonyylimetyyli-imidatsoliumkloridin (65 g)» etanolin (500 ml) ja tolueenin (1+00 ml) muodostamaan liuokseen lisätään dodekametyleeni-diamiinia (1+0 g) ja saatua liuosta kuumennetaan refluksoiden 2b tunnin ajan.Example 2 To a solution of 1-n-octyl-3-ethoxycarbonylmethylimidazolium chloride (65 g) in ethanol (500 ml) and toluene (1 + 00 ml) is added dodecamethylenediamine (1 + 0 g) and the resulting solution is heated at reflux for 2b hours. I drive.
57399 557399 5
Liuottimet haihdutetaan vakuumissa ja jäännös kiteytetään asetonista, joka sisältää vähän vettä, jolloin saadaan 1,1'-dodekametyleenibis(karbamoyylimetyyli)-di(3-n-oktyyli-imidatsoliumkloridi), jonka sulamispiste on 13T-1^0°C.The solvents are evaporated in vacuo and the residue is crystallized from acetone containing a little water to give 1,1'-dodecamethylene bis (carbamoylmethyl) -di (3-n-octylimidazolium chloride), m.p. 13 DEG-1 DEG C.
Lähtöaineena käytetyn 1-n-oktyyli-3-etoksikarbonyylimetyyli-imidatsolium-kloridin liuos voidaan valmistaa seuraavasti:A solution of 1-n-octyl-3-ethoxycarbonylmethylimidazolium chloride used as starting material can be prepared as follows:
Esimerkin 1 mukaan valmistettua 1-n-oktyyli-3~hydroksikarbonyylimetyyli-imidatsoliumkloridia (180 g) ja sulfonoitua polystyreenihartsikatalyyttiä kuumennetaan ja sekoitetaan etanolin (500 ml) ja tolueenin (i+00 ml) kanssa, atseotrooppi-sesti vettä poistaen. 1-n-oktyyli-3-etoksikarbonyylimetyyli-imidatsoliumkloridi muodostuu täydellisesti kahden tunnin kuluttua, jonka jälkeen hartsi suodatetaan " pois.The 1-n-octyl-3-hydroxycarbonylmethylimidazolium chloride prepared according to Example 1 (180 g) and the sulfonated polystyrene resin catalyst are heated and mixed with ethanol (500 ml) and toluene (i + 00 ml), azeotropically removing water. 1-n-Octyl-3-ethoxycarbonylmethylimidazolium chloride is completely formed after two hours, after which the resin is filtered off.
a*a *
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI105473A FI57399C (en) | 1973-04-05 | 1973-04-05 | FREEZING FOR ANTIBACTERIAL VERIFICATION OF IMMEDIATE FACTORS |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI105473 | 1973-04-05 | ||
| FI105473A FI57399C (en) | 1973-04-05 | 1973-04-05 | FREEZING FOR ANTIBACTERIAL VERIFICATION OF IMMEDIATE FACTORS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI57399B true FI57399B (en) | 1980-04-30 |
| FI57399C FI57399C (en) | 1980-08-11 |
Family
ID=8505032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI105473A FI57399C (en) | 1973-04-05 | 1973-04-05 | FREEZING FOR ANTIBACTERIAL VERIFICATION OF IMMEDIATE FACTORS |
Country Status (1)
| Country | Link |
|---|---|
| FI (1) | FI57399C (en) |
-
1973
- 1973-04-05 FI FI105473A patent/FI57399C/en active
Also Published As
| Publication number | Publication date |
|---|---|
| FI57399C (en) | 1980-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3758476A (en) | 2-(thienyl-3'-amino)-1,3-diazacycloalkenes | |
| CN112574089B (en) | A light-induced multifunctional crosslinking agent, its preparation method and application | |
| EP0178035A1 (en) | Anti-inflammatory 1,N-diarylpyrazol-3-amines, compositions containing them and processes for their preparation | |
| US6362351B2 (en) | Catalyst and method for amide formation | |
| SE452610B (en) | SETTING DIVERSE RACEMIC CIS-1,2-CYCLOPROPANDICARBOXYLIC ACID DERIVATIVES | |
| Holla et al. | Studies on arylfuran derivatives: part VII. Synthesis and characterization of some Mannich bases carrying halophenylfuryl moieties as promising antibacterial agents | |
| FI57399B (en) | FREEZING FOR ANTIBACTERIAL VERIFICATION OF IMMEDIATE FACTORS | |
| Hart et al. | [18] Synthesis and characterization of calmodulin antagonistic drugs | |
| CA1042899A (en) | Process for the preparation of furan compounds | |
| PT79375B (en) | NOVEL N-CYCLING BENZENESULFONAMIDES FOR THEIR PREPARATION PROCESS AND THEIR USE AS ACTIVE SUBSTANCES OF PHARMACEUTICAL COMPOSITIONS | |
| CN103341338A (en) | PH sensitive-type single-chain surfactants as well as synthetic method thereof | |
| AU2005276350A1 (en) | Method for preparing N-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives | |
| Tietze et al. | Synthesis of New Water‐Soluble DNA‐Binding Subunits for Analogues of the Cytotoxic Antibiotic CC‐1065 and Their Prodrugs | |
| CN116789604A (en) | 1,3, 4-substituted 2-thioether pyridazine derivative and preparation method thereof | |
| Stevens et al. | Introduction of a triflate group into sterically‐hindered positions in 1‐aryl‐4, 6‐diamino‐1, 3, 5‐triazines and their dimroth rearrangement products | |
| Jovené et al. | A Synthetic Pathway to Substituted Benzofuroxans through the Intermediacy of Sulfonates: The Case Example of Fluoro‐Nitrobenzofuroxans | |
| FI84477C (en) | Process for the preparation of pharmacologically valuable diazine-ethenylphenyloxamic acids | |
| Francis et al. | Fluorous 1, 2, 3-triazol-4-ylmethyl amines and amine derivatives for novel surfactant applications | |
| US3828073A (en) | 4-hydroxy-2h-1-benzothiopyran-3-carboxamides and their corresponding s-oxides | |
| Asundaria et al. | Synthesis, characterization, and antimicrobial evolution of bissydnone based on sulfonamide derivatives | |
| CN101830848B (en) | A kind of polyamine derivative and its preparation method and application | |
| JPH01308268A (en) | Benzotriazole derivative and reagent for analysis of carboxylic acids containing above-mentioned derivative | |
| CN115417859B (en) | A kind of synthesis method of rizatriptan benzoate | |
| CN114478516B (en) | 3, 4-dihydro-2H-quinolizin-2-one compound and preparation method thereof | |
| PL238048B1 (en) | Compounds, derivatives of 2,4,6-trichloro-1,3,5-triazine and method of their preparation |